Gender Equality Remains A Top Priority, Says Cypriot President

by THEFUTURE.TEAM

January 16, 2025

Gender equality remains a core priority for the Government, President Nikos Christodoulides stated on Wednesday during the presentation of the Commissioner for Gender Equality Josie Christodoulou’s report for March–December 2023.

Highlighting the Government’s commitment, President Christodoulides remarked, “There is still much work ahead, but we are encouraged by the progress we’re seeing. It is precisely these results that compel us to continue.” He emphasized that the report’s findings would be thoroughly examined by the Secretariat for Monitoring the Government’s Work to identify obstacles and inefficiencies, ensuring they are addressed in the 2025 annual planning.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Commissioner Christodoulou underscored the Government’s integrated approach, noting that policies promoting work-life balance, the increasing number of women in the Council of Ministers, education reforms, and comprehensive measures to combat violence against women are accelerating progress toward true gender equality. She also informed the President that Cyprus had climbed to 20th place in the European Institute for Gender Equality rankings this year.

“By integrating gender considerations across all Ministries and Deputy Ministries, we are advancing toward substantive equality between women and men,” Christodoulou said while acknowledging that significant challenges remain.

Deputy Minister to the President, Irene Piki, also attended the meeting, reflecting the Government’s united front on gender equality.

A Broader Perspective

While Cyprus doubles down on its commitment to gender equality, the global narrative presents a contrasting picture. In recent months, some companies and institutions have shifted away from Diversity, Equity, and Inclusion (DEI) initiatives, citing either a re-evaluation of priorities or criticism of their efficacy. Cyprus’ steadfast focus on equality amidst this backdrop serves as a reminder that achieving substantial change requires persistence, adaptability, and a clear vision—values that remain at the heart of the Christodoulides administration’s policies.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Breaking news